The acylation stimulating protein-adipsin system

Area of Science:

• Metabolic research
• Endocrinology
• Adipose tissue biology

Background:

• Obesity and abdominal obesity are established risk factors for heart disease and type 2 diabetes.
• Regulation of triacylglycerol synthesis in adipose tissue is primarily understood through insulin's role.
• The function of Acylation Stimulating Protein (ASP) in adipose tissue is not fully elucidated.

Purpose of the Study:

• To investigate the role of Acylation Stimulating Protein (ASP) in regulating triacylglycerol synthesis in adipose tissue.
• To explore ASP's potential physiological functions beyond insulin's known effects.
• To understand ASP's impact on adipose tissue fat storage efficiency and plasma triglyceride clearance.

Main Methods:

• Analysis of Acylation Stimulating Protein (ASP) production in human adipocytes.
• Assessment of ASP's effect on triacylglycerol synthesis in adipose tissue.
• Investigation of ASP's influence on plasma triglyceride metabolism.

Main Results:

• Acylation Stimulating Protein (ASP) was identified as a human plasma protein that stimulates triacylglycerol synthesis in adipose tissue.
• Human adipocytes were found to produce ASP.
• ASP demonstrates a potential role in regulating the efficiency of fat storage in adipose tissue.

Conclusions:

• Acylation Stimulating Protein (ASP) plays a significant role in stimulating triacylglycerol synthesis within adipose tissue.
• ASP's production by adipocytes suggests an autocrine or paracrine function in local fat metabolism.
• ASP may be a key regulator of adipose tissue's capacity for fat storage and contribute to plasma triglyceride homeostasis.